OMEROS CORP Cash
OMEROS CORP (OMER) had Cash of $2.79 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2018-11-08
- 2018-09-30: Cash $2.79M.
- 2018-06-30: Cash $2.90M.
- 2018-03-31: Cash $1.20M.
- 2017-12-31: Cash $3.40M.
| Period end | Cash |
|---|---|
| 2018-09-30 | $2.79M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.20M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.40M 10-Q · filed 2018-11-08 |
| 2017-09-30 | $1.00M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.40M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.30M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.20M 10-K · filed 2018-03-01 |
| 2016-09-30 | $10.30M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $4.60M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $978.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.40M 10-K · filed 2017-03-16 |
| 2015-09-30 | $601.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.60M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.40M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $354.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $750.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.50M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $567.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.20M 10-K · filed 2015-03-16 |
| 2013-09-30 | $1.10M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $1.70M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.30M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.50M 10-K · filed 2014-03-13 |
| 2011-12-31 | $1.60M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |